V026-0605 Screening compound: N-[2-(morpholin-4-yl)ethyl]-N-{2-oxo-2-[4-(6-phenylpyridazin-3-yl)piperazin-1-yl]ethyl}-2-phenylacetamide

V026-0605 Screening compound: N-[2-(morpholin-4-yl)ethyl]-N-{2-oxo-2-[4-(6-phenylpyridazin-3-yl)piperazin-1-yl]ethyl}-2-phenylacetamide
V026-0605 Screening compound: N-[2-(morpholin-4-yl)ethyl]-N-{2-oxo-2-[4-(6-phenylpyridazin-3-yl)piperazin-1-yl]ethyl}-2-phenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V026-0605
N-[2-(morpholin-4-yl)ethyl]-N-{2-oxo-2-[4-(6-phenylpyridazin-3-yl)piperazin-1-yl]ethyl}-2-phenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V026-0605

Molecular Formula

C30H36N6O3 (C30 H36 N6 O3)

Compound Name

N-[2-(morpholin-4-yl)ethyl]-N-{2-oxo-2-[4-(6-phenylpyridazin-3-yl)piperazin-1-yl]ethyl}-2-phenylacetamide

IUPAC name

N-[2-(morpholin-4-yl)ethyl]-N-{2-oxo-2-[4-(6-phenylpyridazin-3-yl)piperazin-1-yl]ethyl}-2-phenylacetamide

SMILES

O=C(Cc1ccccc1)N(CCN1CCOCC1)CC(N(CC1)CCN1c(cc1)nnc1-c1ccccc1)=O

InChI

InChI=1S/C30H36N6O3/c37-29(23-25-7-3-1-4-8-25)36(14-13-33-19-21-39-22-20-33)24-30(38)35-17-15-34(16-18-35)28-12-11-27(31-32-28)26-9-5-2-6-10-26/h1-12H,13-24H2

InChI Key

YWOTVBMIXNMTQP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19828270

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

528.65

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.511

Distribution Coefficient, logD

2.481

Water Solubility, LogSw

-2.38

Polar Surface Area

68.108

Acid Dissociation Constant (pKa)

17.63

Base Dissociation Constant (pKb)

6.26

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.00

V026-0605 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V026-0605 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V026-0605?
Check Price and Availability of V026-0605, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V026-0605 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V026-0605
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V026-0605
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V026-0605 available by request